retatrutide news october 2025 Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS investigation found. Adam Lilly's triple agonist delivers up
Pay in 4 interest-free payments of $6.21 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 27 - Nov 1












:max_bytes(150000):strip_icc()/GettyImages-1336503122-f555bda6176541b8958daa0ca66e953a.jpg)













